WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
One tablet and one capsule daily or as directed by a physician.
Store at 20-25°C (68-77°F) NOTICE: Contact with moisture can discolor or erode the tablet. Six child-resistant blister packs of 5 tablets and 5 capsules each - NDC 0178-0821-30 To report a serious adverse event or obtain product information, call (210) 696-8400. Please consult your health care provider with any dietary concerns. 51072R1120 DHA capsules manufactured for: MISSION PHARMACAL COMPANY San Antonio, TX US...
WARNING:Accidental overdose of iron-containingproducts is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
CitraNatal ®90 DHA is a prescription prenatal/postnatal multivitamin/mineral tablet with Ferr-Ease ®, a patented dual-iron delivery comprising both a quick release and slow release iron, and a capsule of an essential fatty acid. The prenatal vitamin is a white, oval multivitamin/mineral tablet. The tablet is debossed “CN 90” on one side and “0821” on the other. The essential fatty acid DHA capsule is caramel colored and contains a light yellow to orange semi-solid mixture.
| Vitamin C (Ascorbic acid) | 120 mg |
| Calcium (Calcium citrate) | 159 mg |
| Iron (Carbonyl iron, ferrous gluconate) | 90 mg |
| Vitamin D3 (Cholecalciferol) | 400 IU |
| Vitamin E (dl-alpha tocopheryl acetate) | 30 IU |
| Thiamin (Vitamin B1) | 3 mg |
| Riboflavin (Vitamin B2) | 3.4 mg |
| Niacinamide (Vitamin B3) | 20 mg |
| Vitamin B6 (Pyridoxine HCl) | 20 mg |
| Folic Acid | 1 mg |
| Iodine (Potassium iodide) | 150 mcg |
| Zinc (Zinc oxide) | 25 mg |
| Copper (Cupric oxide) | 2 mg |
| Docusate Sodium | 50 mg |
| Docosahexaenoic | |
| Acid(DHA, 40% from 750 mg Algal Oil) | 300 mg |
| Eicosapentaenoic Acid (EPA) | Not more than 0.750 mg |
Other ingredients in DHA gelatin capsule: Gelatin, glycerin, sunflower oil, water, caramel color, tocopherols, rosemary extract, sunflower lecithin, ascorbyl palmitate.
CitraNatal ®90 DHA is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.
WARNING:Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B 12is deficient.
Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
One tablet and one capsule daily or as directed by a physician.
Store at 20-25°C (68-77°F)
NOTICE:Contact with moisture can discolor or erode the tablet.
Six child-resistant blister packs of 5 tablets and 5 capsules each - NDC0178-0821-30
To reporta serious adverse event or obtain product information, call (210) 696-8400.
Please consultyour health care provider with any dietary concerns.
51072R1120
DHA capsules manufactured for:
MISSION PHARMACAL COMPANY
San Antonio, TX USA 78230 1355
Prenatal tablets manufactured by:
MISSION PHARMACAL COMPANY
San Antonio, TX USA 78230 1355
Ferr-Ease™
Dual-iron delivery
Trademark of Mission Pharmacal Company
CitraNatal
®
90DHA Carton
NDC: 0178-0821-30
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0301780821305 | GTIN-13: 0301780821305 EAN-13: 0301780821305 GTIN-12: 301780821305 UPC-A: 301780821305 GTIN storage (14 digits): 00301780821305 | CNN_12320_51072R1120_CitraNatal 90DHA Retail Carton_FNL_VP.jpg |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0178-0821-30 | 2020-04-06 | C162847 | 48780-1 | 9d75b9d0-3871-f424-e053-dadaa90a57ce | CitraNatal ® 90 DHA |
| 0178-0821-30 | 2020-04-06 | C162847 | 48780-1 | 9d75b9d0-3871-f424-e053-dadaa90a57ce | CitraNatal ® 90 DHA |
| 0178-0821-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3871-f424-e053-dadaa90a57ce | CitraNatal ® 90 DHA |
| 0178-0821-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3871-f424-e053-dadaa90a57ce | CitraNatal ® 90 DHA |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0178-0821-30 | CitraNatal 90 DHA | 5 in 1 BLISTER PACK | TABLET | 5 | 10 | |
| 0178-0821-30 | CitraNatal 90 DHA | 6 in 1 CARTON | TABLET | 6 | 10 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0178-0821-30 | EA - Each | 0178-0821 | 0834089a-b38b-4162-a730-dc20a8d5a3ba | 1 | 2014-05-02 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .ALPHA.-TOCOPHEROL ACETATE | ACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| ASCORBIC ACID | ACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| CALCIUM CITRATE | ACTIVE INGREDIENT | MLM29U2X85 | 1 | |
| CUPRIC OXIDE | ACTIVE INGREDIENT | V1XJQ704R4 | 1 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | 1 | |
| FOLIC ACID | ACTIVE INGREDIENT | 935E97BOY8 | 1 | |
| IRON | ACTIVE INGREDIENT | E1UOL152H7 | 1 | |
| NIACINAMIDE | ACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| POTASSIUM TRIIODIDE | ACTIVE INGREDIENT | T66M6Y3KSA | 1 | |
| PYRIDOXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 68Y4CF58BV | 1 | |
| RIBOPRINE | ACTIVE INGREDIENT | 8EU82FAZ5J | 1 | |
| THIAMINE | ACTIVE INGREDIENT | X66NSO3N35 | 1 | |
| VITAMIN D | ACTIVE INGREDIENT | 9VU1KI44GP | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| .ALPHA.-TOCOPHEROL | ACTIVE MOIETY | H4N855PNZ1 | 1 | |
| ASCORBIC ACID | ACTIVE MOIETY | PQ6CK8PD0R | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| CHOLECALCIFEROL | ACTIVE MOIETY | 1C6V77QF41 | 1 | |
| CUPRIC CATION | ACTIVE MOIETY | 8CBV67279L | 1 | |
| DOCUSATE | ACTIVE MOIETY | M7P27195AG | 1 | |
| FOLIC ACID | ACTIVE MOIETY | 935E97BOY8 | 1 | |
| IRON | ACTIVE MOIETY | E1UOL152H7 | 1 | |
| NIACINAMIDE | ACTIVE MOIETY | 25X51I8RD4 | 1 | |
| PYRIDOXINE | ACTIVE MOIETY | KV2JZ1BI6Z | 1 | |
| RIBOPRINE | ACTIVE MOIETY | 8EU82FAZ5J | 1 | |
| THIAMINE ION | ACTIVE MOIETY | 4ABT0J945J | 1 | |
| TRIIODIDE ION | ACTIVE MOIETY | DA1N05631Q | 1 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| ACRYLIC ACID | INACTIVE INGREDIENT | J94PBK7X8S | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 1 | |
| ETHYL VANILLIN | INACTIVE INGREDIENT | YC9ST449YJ | 1 | |
| FERROUS GLUCONATE | INACTIVE INGREDIENT | U1B11I423Z | 1 | |
| MAGNESIUM SILICATE | INACTIVE INGREDIENT | 9B9691B2N9 | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | 1 | |
| THIAMINE MONONITRATE | INACTIVE INGREDIENT | 8K0I04919X | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| VITAMIN A PALMITATE | INACTIVE INGREDIENT | 1D1K0N0VVC | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0178-0821 | 0178-0821-30 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ASCORBIC ACID | PQ6CK8PD0R | ACTIB |
| IRON | E1UOL152H7 | ACTIB |
| .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | ACTIM |
| THIAMINE | X66NSO3N35 | ACTIB |
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
| PYRIDOXINE HYDROCHLORIDE | 68Y4CF58BV | ACTIB |
| FOLIC ACID | 935E97BOY8 | ACTIB |
| ZINC OXIDE | SOI2LOH54Z | ACTIB |
| CUPRIC OXIDE | V1XJQ704R4 | ACTIM |
| DOCUSATE SODIUM | F05Q2T2JA0 | ACTIB |
| CALCIUM CITRATE | MLM29U2X85 | ACTIR |
| THIAMINE MONONITRATE | 8K0I04919X | ACTIR |
| POTASSIUM IODIDE | 1C4QK22F9J | ACTIB |
| FERROUS GLUCONATE | U1B11I423Z | ACTIM |
| VITAMIN D | 9VU1KI44GP | ACTIB |
| RIBOFLAVIN | TLM2976OFR | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 9 | 2024-01-08 | full-release | 2026-05-31 20:57:41 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| ETHYL VANILLIN | ETHYL VANILLIN | YC9ST449YJ | CAPSULE, EXTENDED RELEASE / ORAL | NA | ||
| ETHYL VANILLIN | ETHYL VANILLIN | YC9ST449YJ | CAPSULE / ORAL | 0.64 mg | ||
| ETHYL VANILLIN | ETHYL VANILLIN | YC9ST449YJ | PASTE / ORAL | 7 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| MAGNESIUM SILICATE | MAGNESIUM SILICATE | 9B9691B2N9 | TABLET / ORAL | 10 mg | ||
| MAGNESIUM SILICATE | MAGNESIUM SILICATE | 9B9691B2N9 | TABLET / ORAL | 10 mg | ||
| ETHYL VANILLIN | ETHYL VANILLIN | YC9ST449YJ | CAPSULE, EXTENDED RELEASE / ORAL | NA | ||
| ETHYL VANILLIN | ETHYL VANILLIN | YC9ST449YJ | SUSPENSION / ORAL | 0.08 mg/5ml | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| ETHYL VANILLIN | ETHYL VANILLIN | YC9ST449YJ | SYRUP / ORAL | NA | ||
| ETHYL VANILLIN | ETHYL VANILLIN | YC9ST449YJ | PASTE / ORAL | 7 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| ETHYL VANILLIN | ETHYL VANILLIN | YC9ST449YJ | SUSPENSION / ORAL | 0.08 mg/5ml | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| ETHYL VANILLIN | ETHYL VANILLIN | YC9ST449YJ | CAPSULE / ORAL | 0.64 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| ETHYL VANILLIN | ETHYL VANILLIN | YC9ST449YJ | SYRUP / ORAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CitraNatal 90 DHA | VITAMIN C, CALCIUM, IRON, VITAMIN D3, VITAMIN E, THIAMIN, RIBOFLAVIN, NIACINAMIDE, VITAMIN B6, FOLIC ACID, IODINE, ZINC, COPPER, DOCUSATE SODIUM | Mission Pharmacal Company | 81e639d7-352e-4eaa-87d9-582da68b9728 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 0178-0821-30 0178-0821 00178082130 47e820ed-a6e9-4961-e063-6394a90ad041 81e639d7-352e-4eaa-87d9-582da68b9728 |
Adverse event summaries are temporarily unavailable. Other product information remains available.